The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR(PDF, 524KB) and Technical Notes(PDF, 752KB) pages.


Download and Print: Download Printer-friendly PDF Download data


Figure 1.19

CSR Figure 1.19: Person and Average Years of Life Lost by Cancer Site


Figure 1.19

Years of Life Lost in 2015 due to Cancer
All Races, Both Sexes

Person-Years of Life

Cancer SiteIncidence
Person-Years of Life Lost in Thousands of Years
All Cancer Sites 9377.0
Lung & Bronchus 2335.9
Colon & Rectum 822.0
Breast (Female) 785.3
Pancreas 631.4
Liver & IBD 442.9
Leukemia 359.2
Brain & ONS 350.9
Prostate 289.2
Non-Hodgkin Lymphoma 282.1
Ovary 247.1
Esophagus 245.3
Kidney & Renal Pelvis 226.2
Stomach 187.3
Urinary Bladder 184.1
Corpus & Uterus, NOS 177.7
Myeloma 168.4
Oral Cavity & Pharynx 167.0
Melanoma of the Skin 147.9
Cervix Uteri 110.9
Childhood Ages (0-14) 91.6
Hodgkin Lymphoma 22.9
Testis 13.1

Average Years of Life Lost

Cancer SiteIncidence
Average Years of Life Lost in Years
Childhood Ages (0-14) 72.0
Testis 35.1
Cervix Uteri 26.6
Brain & ONS 21.6
Hodgkin Lymphoma 20.5
Breast (Female) 18.9
Ovary 17.8
Corpus & Uterus, NOS 17.6
Liver & IBD 17.2
Oral Cavity & Pharynx 17.1
Melanoma of the Skin 16.6
Stomach 16.5
Esophagus 16.1
All Cancer Sites 15.7
Leukemia 15.7
Colon & Rectum 15.7
Kidney & Renal Pelvis 15.7
Lung & Bronchus 15.2
Pancreas 15.2
Non-Hodgkin Lymphoma 14.0
Myeloma 13.8
Urinary Bladder 11.3
Prostate 10.0

Footnotes:

Source: US Mortality Files, National Center for Health Statistics, Centers for Disease Control and Prevention and 2014 Life Tables.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.